WVE Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: Positive Duchenne data supports accelerated approval, attractive in high RNA therapy demand environment.




Bearish Case: Regulatory setbacks and limited historical returns pose significant risks, coupled with high volatility.




Potential Outcomes:
  • Successful Trials: 30%
  • Regulatory Setbacks: 25%
  • Flat Performance: 20%
  • Breakthrough Partnerships: 15%
  • Negative Market Trends: 10%



April 24, 2025


Wave Life Sciences Forecast

WVE        Wave Life Sciences











Correlated Assets

Assets that tend to move strongly with WVE



MTB Forecast + Options Trading Strategies   MTB  M & T (0.87)


BLK Forecast + Options Trading Strategies   BLK  Blackrock (0.86)


BAM Forecast + Options Trading Strategies   BAM  Brookfield Asset (0.84)


MAC Forecast + Options Trading Strategies   MAC  Macerich (0.83)


RJF Forecast + Options Trading Strategies   RJF  Raymond James Financial (0.83)



Uncorrelated Assets

Assets with little price relationship to WVE



BBWI Forecast + Options Trading Strategies   BBWI  Bath & Body Works (0.0)


DAN Forecast + Options Trading Strategies   DAN  Dana (0.0)


FDX Forecast + Options Trading Strategies   FDX  Fedex (0.01)


JDST Forecast + Options Trading Strategies   JDST  Direxion Daily Junior Gold Miners Index Be (-0.01)


CRSR Forecast + Options Trading Strategies   CRSR  Corsair Gaming (-0.02)



Anticorrelated Assets

Assets that tend to move strongly against WVE



UDN Forecast + Options Trading Strategies   UDN  Invesco DB US Dollar Index Bearish (-0.71)


BMRN Forecast + Options Trading Strategies   BMRN  Registered Shares (-0.72)


PAGS Forecast + Options Trading Strategies   PAGS  PagSeguro Digital (-0.74)


EC Forecast + Options Trading Strategies   EC  Ecopetrol SA (-0.77)


DOG Forecast + Options Trading Strategies   DOG  ProShares Short Dow30 (-0.79)









Become a more profitable investor with AI optimized trading strategies






×

Chat with WVE


 Ask any question about WVE!